M. Mornet

Subcutaneous heparin treatment increases survival in small cell lung cancer

B Lebeau, Claude Chastang, J.-M. Bréchot et al. · Cancer · 1994 · 277 citations · Full text

Medicine, Oncology, Pharmacology +8

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials

Thomas Aparicio, Michel Ducreux, Roger Faroux et al. · European Journal of Cancer · 2018 · 46 citations · Full text

Medicine, Nutrition, Oncology +9

Molecular Characterization of a New <i>Tetratrichomonas</i> Species in a Patient with Empyema

Cléa Mantini, Laetitia Souppart, Christophe Noël et al. · Journal of Clinical Microbiology · 2009 · 38 citations · Full text

Medicine, Infectious Diseases, Microbiology +17

Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel–cisplatin versus vinorelbine–cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study

Jean‐Yves Douillard, R. Gervais, G Dabouis et al. · Annals of Oncology · 2004 · 37 citations

Medicine, Oncology, Pharmacology +17

Standard combination versus alternating chemotherapy in small cell lung cancer

T. Urban, T. Baleyte, Claude Chastang et al. · Lung Cancer · 1999 · 19 citations

Medicine, Oncology, Chemotherapy +8